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Historically, genetically engineered (GE) plants that have incorporated genes conferring
insect protection have primarily used Cry proteins derived from Bacillus thuringiensis
(Bt) to achieve their insecticidal phenotype. As a result, regulators have developed a
level of familiarity and confidence in reviewing plants incorporating these insecticidal
proteins. However, new technologies have been developed that produce GE plants
that incorporate pest protection by triggering an RNA interference (RNAi) response or
proteins other than Bt Cry proteins. These technologies have new modes of action.
Although the overall assessment paradigm for GE plants is robust, there are ongoing
discussions about the appropriate tests and measurement endpoints needed to inform
non-target arthropod assessment for technologies that have a different mode of action
than the Bt Cry proteins. As a result, increasing attention is being paid to the use of
sublethal endpoints and their value for environmental risk assessment (ERA). This review
focuses on the current status and history of sublethal endpoint use in insect-active
GE crops, and evaluates the future use of sublethal endpoints for new and emerging
technologies. It builds upon presentations made at theWorkshop on Sublethal Endpoints
for Non-target Organism Testing for Non-Bt GE Crops (Washington DC, USA, 4–5 March
2019), and the discussions of government, academic and industry scientists convened
for the purpose of reviewing the progress and status of sublethal endpoint testing in
non-target organisms.
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INTRODUCTION
The introduction of insect-resistant GE crops began in the
1990s, with a number of today’s crops incorporating Bt Cry
proteins (Koch et al., 2015; Naranjo et al., 2020). According
to the International Service for the Acquisition of Agri-
biotech Applications (ISAAA) GM Approval database1, 85
transformation events involving Bt Cry protein expressed in 10
crops received regulatory approval somewhere in the world by
the end of 2019. These have been further incorporated into
206 stacks (that combine two or more GE traits) that have
received additional regulatory approvals1. These approvals have
each been accompanied by an ERA that has typically focused
on identifying the target range and specificity of the Bt Cry
proteins using a tiered approach to non-target testing that is
very similar to the approach used in the assessment of chemical
pesticides (Garcia-Alonso et al., 2006; Romeis et al., 2008;
Figure 1). Tier-1 testing involves the use of surrogate species
tested under worst-case exposure conditions in the laboratory to
identify potential hazards to them. Specific endpoints, typically
including mortality, are measured in tier-1 tests under conditions
of exposure to concentrations, usually several fold higher than
concentrations expected in the field (Romeis et al., 2008).
In the absence of relevant negative effects in test species at
high exposures, a conclusion that the likelihood of adverse
ecological effects under realistic conditions is low or negligible
can be supported (Romeis et al., 2013b). If negative effects are
observed under worst-case conditions, then higher tier studies
are conducted to establish if the effect is relevant under more
realistic conditions (i.e., lower dose; Rose, 2007; EFSA, 2010;
Figure 1).
After more than 20 years of use in the field, there is a
substantial history associated with GE plants incorporating Bt
Cry proteins and their safety in the environment (Mendelsohn
et al., 2003; Naranjo, 2009; Duan et al., 2010; Center for
Environmental Risk Assessment, 2012; Guo et al., 2014; Koch
et al., 2016; Romeis et al., 2019). The utility of a tiered
approach using mortality as the primary endpoint is supported
by experience with Bt Cry proteins and by an understanding
of the mode of action, target specificity and exposure levels for
these proteins. However, new pest control technologies, including
non-Bt Cry proteins and the use of RNAi, have led to an
increased interest in sublethal endpoints testing. This interest
is due to several factors, including broader interest in sublethal
impacts of chemicals, differences in the mode of action, and
the length of time required to observe an effect, and concerns
about cumulative or additive effects of multiple stressors in
the environment.
While the use of sublethal endpoints is potentially informative
for the ERA of non-Bt GE plants, there are a number of
challenges to implementing this approach. These include the
wide variety of potential endpoints from which to choose
and difficulties interpreting the relationship between sublethal
endpoints in laboratory studies and observable effects in the field.
This paper addresses some of these challenges by examining
1http://www.isaaa.org/gmapprovaldatabase/
sublethal endpoints in the context of insect-resistant GE plants
and considering when inclusion of sublethal endpoints may or
may not be warranted in the context of problem formulation for a
case-specific ERA. This review has been informed by discussions
at a workshop convened by the ILSI Research Foundation
(Washington, DC, USA, 4–5March 2019) that asked participants
to consider the relevance of sublethal endpoint testing using a
case study approach.
NON-TARGET ORGANISM ASSESSMENT
Problem Formulation
The process of identifying and refining the information that
will be informative for case-specific ERA is referred to as
problem formulation (USEPA, 2016). The mechanics of problem
formulation can be described in a number of ways (Hill, 2005;
OGTR, 2009; Wolt et al., 2010; Gray, 2012), but the process
involves a series of steps that incorporate context for the decision
being made, information about the receiving environment and
the societal values or protection goals that are identified in
relevant laws and regulations. Because these protection goals
are often broad, case specific ERA requires the refinement of
operational protection goals and the subsequent identification
of assessment endpoints, which allow the testing of relevant
hypotheses to inform the assessment (Sanvido et al., 2012; Devos
et al., 2015). Data are then collected under laboratory, semi-field
or field conditions for measurement endpoints that are related
to those assessment endpoints (Garcia-Alonso and Raybould,
2014). The advantage of problem formulation is that it provides
an explicit rationale for how and why a particular measurement
endpoint will be informative to an ERA (Figure 2).
For most risk assessments on non-target invertebrates,
operational protection goals are reliant on maintaining
populations of value or beneficial arthropods that contribute to
important ecosystem services (Devos et al., 2015). Among the
most relevant have been populations of pollinators, parasitoids,
and predators as well as charismatic, protected, threatened, or
endangered species, for which an exposure assessment indicates
they will have a meaningful exposure to the GE plant. Once the
particular species of interest are identified, appropriate surrogate,
indicator, or focal species are selected for testing (Rose, 2007;
EFSA, 2010).
NTO Study Design
As with any research or regulatory study, the design of an
non-target organism (NTO) study must be appropriate for the
intended end use of the data. Well-designed early-tier studies
are intended to identify any hazards that require further study.
Careful consideration, therefore, must be given to ensuring
that tests are reliable and especially that false negative results
(i.e., failing to identify a hazard) are avoided since they would
lead to the release of hazardous material. False positive results,
on the other hand, also should be avoided since they might
have consequences, even beyond the triggering of additional
studies (Romeis et al., 2013a). The first step is to identify
appropriate surrogate species (Carstens et al., 2014). These
should be chosen based on the representativeness of species
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FIGURE 1 | This figure details the tiered structure of testing used during the ERA process. This is hypothesis-based testing, where the initial tests are conducted at
doses higher than what is encountered in a natural setting to simulate a worst-case scenario exposure. Example risk hypotheses are provided for NTOs to
demonstrate how this structure can be used to test sub-lethal effects. This figure was adapted from Romeis et al. (2008).
of importance in the expected receiving environment, and
ideally represent a functional group of interest. As a practical
consideration, it is useful to select a surrogate from readily
available laboratory reared strains. This provides uniformity
to the test and control groups as well as reproducibility of
results obtained from multiple laboratories. A surrogate species
may additionally be selected based on its sensitivity to the
test substance, taking into account what is known about the
spectrum of activity of the insecticidal protein. For example,
when the surrogate species and the target pests are more closely
related phylogenetically, it is more probable that the surrogate
species will be sensitive to the test substance (Romeis et al.,
2013a). NTO tests should be designed to expose the surrogate
to the test substance in a way that maximizes the likelihood of
detecting an effect and represents a relevant exposure pathway
(e.g., dietary exposure). While juveniles are usually expected
to be more susceptible in some species, other species may
instead or also have susceptible adults, so it is advantageous
to test multiple life stages provided there is a reasonable
exposure pathway for those life stages (Romeis et al., 2011,
2013b).
When designing the study protocol, the most expedient
approach is to use an already available artificial diet into
which both test substances and positive controls can be
easily incorporated. This allows the concentrations of the
test substance to exceed the expected environmental exposure
in order to test levels that exceed worst-case exposures.
If an artificial diet is not available, or not suitable for
incorporation of the test substance, then GE plant material
can be used. However, this may limit the test dose possibilities
and reduces the margin of exposure. Furthermore, it might
be a challenge to identify the appropriate non-transformed
control material.
The use of appropriate controls is a critical component for
ensuring that test results are reliable and meaningful (Romeis
et al., 2011). When plant material is used as a test substance,
near-isogenic lines are preferred as a control in order to eliminate
confounding variables in the composition of the materials,
unrelated to the GE trait. For NTO studies, negative controls
should be designed to mimic the test conditions as closely
as possible, and usually use the same test diet with an inert
ingredient in place of the test substance. Negative controls also
are essential to evaluate if specific a priori assay performance
criteria were met (e.g., level of acceptable control mortality),
to ensure that any observed effects are not due to nutritional
inadequacies, failure of the test arthropods to eat the diet or
inappropriate conditions in the experimental design for the
health of the test arthropods. Similarly, positive controls are
recommended to ensure that the test system is functioning
as intended. This includes verifying that the test animal is
consuming the test substance. To ensure this, having a positive
control that closely mimics the mode of action, or at least
requires the same route of exposure as the test substance is
desirable. Moreover, recombinant insecticidal proteins produced
in microorganisms are often used as the test substance in place of
plant derived proteins because of the impracticality of purifying a
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FIGURE 2 | This figure provides details of the broad steps used in the risk
assessment process. All risk assessments start with problem formulation to
develop the hypotheses that need to be tested. Once problem formulation is
completed risk characterization is conducted with analysis of exposure and
testing to determine the potential effects of the exposure. Data from the risk
characterization studies are used in the risk evaluation process. This figure
was adapted from Wolt et al. (2010).
sufficient quantity of protein from the plants. For this reason, it is
important to assess the functional and biochemical equivalence
of the test substance with the protein expressed by the GE
crop (Raybould et al., 2013). Another aspect to consider is the
biological activity of the test substance in the diet: a parallel
bioassay is usually performed using a target species in order to
check that the insecticidal protein is stable and has the expected
level of biological activity in the diet. In practice, not every test
system is able to meet the definition of an ideal NTO study.
However, as long as the methods and protocols are reported
accurately and the limitations of the study are understood and
explained, these studies should still be considered in a weight-
of-evidence approach. As a minimum standard, tier 1 studies
should include a worst-case-exposure scenario, confirmation that
the test species is exposed to the biologically active test substance,
and the use of a negative experimental control (De Schrijver et al.,
2016).
Measurement Endpoints in NTO Testing
Historically, the primary and most common measurement
endpoint for an early tier laboratory study is mortality. There
are a number of reasons for this, including that it is normally
unambiguous, easy to measure and has a clear and direct
relationship to potential adverse effects on populations of NTOs
and ecosystem services they provide. Because it is a common
endpoint, there are study designs and methods described for
measuring mortality in multiple test systems and for many test
species that are validated. Adherence to these standards is often
encouraged or required for submitting study results associated
with regulatory reviews.
One advantage of using mortality as a study endpoint is
that regulatory agencies have developed policies and practices
associated with interpreting the results of mortality in NTO
studies in regulatory risk assessments. A white paper generated
by a panel of experts suggested 50% mortality or a 50% impact
on development or weight at the maximum hazard dose in tier 1
studies with insecticidal proteins as a reasonable threshold value
for determining if higher tier studies will be informative (Rose,
2007). The European Food Safety Authority (EFSA) recommends
a multiplicative effect of 20% in tier 1 laboratory studies in
order to trigger additional studies (EFSA, 2010). One criticism of
looking at mortality as a measurement endpoint is that it may not
be protective for sublethal effects that might impact populations
and the ecological services provided by NTOs. While this is
certainly true, it is mitigated by achieving a sufficient margin of
exposure, margin of safety or other conservative features of NTO
study design.
While it is often remarked that mortality is the only endpoint
used in in the regulatory risk assessment of Bt Cry proteins
(Andow and Hilbeck, 2004; Desneux and Bernal, 2010), this is
not the case. As shown in Table 1, although mortality is the
most common measurement endpoint, it is not unusual to see
one or more sublethal endpoints recorded for a regulatory study
(e.g., larval weight and development time can be collected when
conducting lethality testing provided the test is of sufficient
duration for the test species to reach developmental milestones).
Most regulatory studies on insecticidal proteins have also
recorded sublethal endpoints, but these data are not always
reported in summaries or subsequent representation of the study.
Sublethal endpoints that have been measured in studies for Bt
Cry proteins include larval and adult weight, developmental
timing, fecundity (number of offspring), percent completing
adult development and even mobility. What is equally apparent
from Table 1 is that while sublethal endpoints have been
measured, sometimes it is not immediately obvious how or why
particular data on sublethal endpoints are collected, and there
is little consistency in how those endpoints are reported in the
literature. This is not unexpected as these measurements are
selected and coordinated by individual product managers in the
absence of specific data requirements. Standardized and validated
test protocols used to assess foliar applications of pesticides
published by the International Organization for Biological and
Integrated Control of Noxious Animals and Weeds (IOBC)
include methods for a total of nine beneficial species (two
parasitoids, seven predators) and can inform NTO testing for
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GE plants. With the exception of one beetle species (Aleochara
bilineata, Coleoptera: Staphylinidae), all IOBC protocols assess
mortality as an endpoint (Candolfi et al., 2000). In addition,
the tests also considered sublethal endpoints, mainly based
on reproduction but also food consumption and behavior of
the organism.
The selection of measurement endpoints associated with NTO
assessment should be guided by a proper problem formulation
that incorporates case-specific information pertinent to the
assessment. In this way, measurement endpoints are selected that
are clearly linked to an assessment endpoint and associated with
the risk hypothesis. Risk hypotheses should not be generic, but
rather case-specific and informed by what is known about the
insect active routes of exposure and its effects on sensitive or
target species. Also, prior to the study, the project managers and
risk assessors should know specifically how the measurement
endpoints will be interpreted and how they will be used in
the decision process. If it cannot be clearly articulated how
study results will inform the assessment, then the measurement
endpoints for the study may not be well-aligned with protection
goals and decision-making priorities. Finally, the measurement
endpoints should be designed to incorporate the practical
realities and limitations associated with available and appropriate
relevant test species.
EXPERIENCE WITH SUBLETHAL
ENDPOINT TESTING IN NON-Bt GE
CROPS
The development of novel, non-Bt Cry proteins for insect
control and of non-protein based methods such as RNAi
has been accompanied by an increased interest in assessing
sublethal impacts. Publications related to these new technologies
demonstrate some of the ways that sublethal endpoints are used.
RNAi and MON87411
The potential use of RNAi for pest control has been widely
discussed (Burand and Hunter, 2013) and regulators are
considering the use of RNAi to control insect pest in relation to
risk assessment (USEPA, 2014; Casacuberta et al., 2015; Roberts
et al., 2015). Presently, a single insect protected crop using
RNAi as a mechanism has been approved for commercialization.
The effect of the RNAi in the target pest, the western corn
rootworm (WCR, Diabrotica virgifera virgifera), is triggered
by the presence of a dsRNA targeting a housekeeping gene.
MON87411 targets the WCR Snf7 gene and its mode of action
has been well-characterized (Bolognesi et al., 2012; Ramaseshadri
et al., 2013). Uptake of DvSnf7 RNA generates eventual mortality
or severe growth inhibition, which can be observed 5 days
after exposure to the test substance. There is also a relationship
between exposure duration and eventual growth inhibition at
lower doses, but short exposures at high doses are sufficient
to induce mortality (Bolognesi et al., 2012). A description of
the published ERA for MON87411 expressing DvSnf7 RNA,
includes a description of NTO testing conducted in support of
the risk assessment (USEPA, 2015; Bachman et al., 2016). A
range of vertebrate tests were conducted, as well as arthropod
testing including toxicity assays for seven species of arthropod.
In addition to mortality, sublethal endpoints were observed
for each species and included measures of time to adulthood,
percent adult emergence, adult biomass (weight), and fecundity
(number of surviving offspring produced). Tests were conducted
with concentrations of the test substance in excess of 10-fold
the maximum expected environmental concentration and the
duration of the test period was in excess of the time required
to see an effect in the target species. The selection of surrogate
species took into account the mode of action, considering that
coleopterans (beetles) show significantly greater sensitivity to
ingested dsRNA than other arthropod orders (Roberts et al.,
2015). Because this order of insect includes the target species,
WCR, it provides a good illustration of how phylogenetic
relationships and an understanding of the mode of action can
facilitate the choice of surrogates. Additionally, bioinformatics
was used as a complementary tool to perform a screening and
to identify potential surrogate species based upon the presence of
sequence matches. Sequence alignment between the genome and
DvSnf7 informed the number and type of species tested, focusing
on those which were considered most likely to be informative
(Bachman et al., 2016).
Non-Bt Cry Insecticidal Proteins: IPD072Aa
One example of a non-Bt insecticidal protein that has been
subject to extensive NTO assessment is IPD072Aa, isolated
from Pseudomonas chlororaphis, which has activity against WCR
(Schellenberger et al., 2016). The IPD072Aa protein has been
the subject of bioassays to determine the spectrum of activity
in order to inform the NTO risk assessment (Boeckman et al.,
2019). As the target pest is a coleopteran, bioassays were
conducted with 11 species of Coleoptera, representing four
families. Additionally, four species of lepidopteran (moths and
butterflies) representing four families in this order were tested.
Measurement endpoints included mortality as well as weight for
all but one species tested, and time to emergence for two species
of ladybird beetles. No observed effects were reported for any of
the Lepidoptera species, but both mortality and sublethal effects
were observed at varying protein concentrations in some of the
tested Coleoptera. In line with best practices for NTO study
design (see NTO Study Design above) the criteria for selection
of species to characterize the spectrum of activity of IPD072Aa
was based on several factors such as the phylogenetic relationship
between the species and WCR, established laboratory bioassay
methodologies, availability of laboratory reared insects, a known
suitable diet and reproducibility of the measurement endpoints
(Boeckman et al., 2019).
IPD072Aa has a midgut site of action (SOA) where it targets
and disrupts midgut epithelial cells causing breakdown of the
epithelial lining in WCR through what appears to be a non-
pore forming mechanism (Schellenberger et al., 2016). The
ability of IPD072Aa to kill WCR larvae resistant to mCry3A
or Cry34Ab1/Cry35Ab1 indicates that its target site differs from
those of the Bt Cry proteins (Carlson et al., 2019). This knowledge
related to its mode of action and the phylogentic relationship
between the candidate surrogate species and WCR will guide
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TABLE 1 | Laboratory studies with beneficial non-target invertebrates (predators, parasitoids, pollinators) or surrogate species for the soil and aquatic environment to
support the regulatory risk assessments of plant expressed insecticidal Bt Cry proteins.
Species Life-stage exposed Measurement endpoints References
Predators
Aleochara bilineata Adults Fecundity, offspring survival Stacey et al., 2006a
Fecundity Raybould and Vlachos, 2011
Coccinella septempunctata Larvae Mortality, development time, adult weight De Schrijver et al., 2016b
Larvae, adults Larval mortality, development time, adult mortality Stacey et al., 2006a;
Development time, adult weight, fecundity, fertility De Schrijver et al., 2016b
Adults Mortality Raybould and Vlachos, 2011
Coleomegilla maculata Larvae Mortality, development time, adult weight Duan et al., 2002; Devos et al.,
2012c; De Schrijver et al., 2016b;
Bachman et al., 2017
Mortality, weight De Schrijver et al., 2016b
Adults Mortality, adult weight fecundity Duan et al., 2002
Mortality Raybould and Vlachos, 2011;
Devos et al., 2012c
Hippodamia convergens Adults Mortality Devos et al., 2012c; De Schrijver
et al., 2016b
Poecilus chalcites Larvae Mortality, development time, development rate, weight Duan et al., 2006
Poecilus cupreus Larvae Mortality, adult weight Stacey et al., 2006a
Mortality, Development time, adult weight De Schrijver et al., 2016b
Orius insidiosus Nymphs Mortality, percent developing into adults Stacey et al., 2006; Duan et al.,
2008a; Bachman et al., 2017
Mortality Raybould and Vlachos, 2011; De
Schrijver et al., 2016b
Orius laevigatus Nymphs Mortality, development time De Schrijver et al., 2016b
Chrysoperla carnea Larvae Mortality Raybould and Vlachos, 2011;
Devos et al., 2012c; De Schrijver
et al., 2016b
Parasitoids
Pediobius foveolatus Adults Mortality Bachman et al., 2017
Nasonia vitripennis Adults Mortality Devos et al., 2012c; De Schrijver
et al., 2016b
Pollinator
Apis mellifera Larvae Mortality Duan et al., 2008; Raybould and
Vlachos, 2011; Devos et al.,
2012; Bachman et al., 2017c
Mortality, development time Devos et al., 2012c; De Schrijver
et al., 2016b
Brood development Raybould et al., 2007
Adults Mortality Duan et al., 2008; Devos et al.,
2012c
Soil organism
Folsomia candida Juveniles Mortality, number of offspring Raybould and Vlachos, 2011;
Devos et al., 2012c; De Schrijver
et al., 2016b; Bachman et al.,
2017
Aquatic organisms
Daphnia magna Juveniles Mortality Devos et al., 2012c
Mobility De Schrijver et al., 2016b
Culex quinquefasciatus Larvae Mortality De Schrijver et al., 2016b
This table only represents sublethal endpoint data collected as part of a regulatory study and does not present sublethal endpoint data collected as part of solely academic studies.
aData provided in Stacey et al. (2006) are also listed in Raybould et al. (2007). Raybould et al. (2007) summarizes the data that were submitted to the regulatory authority. Interestingly,
for all but one of the organisms tested (O. insidiosus; P. cupreus; and A. bilineata) not all sublethal endpoint measured by Stacey et al. (2006) are also reported by Raybould (2007).
bDe Schrijver et al. (2016) lists unpublished data from regulatory studies.
cDevos et al. (2012) lists unpublished data from regulatory studies.
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selection of the appropriate surrogate species and measurement
endpoints in NTO assays.
Non-Cry Insecticidal Proteins: Vip3A
Vip3A is a Bt vegetative insecticidal protein that is active against
lepidopteran pests. It has a different mode of action from Cry
proteins, and when delivered as a combined treatment it has the
potential to delay the evolution of pest resistance to Bt crops
(Lee et al., 2003). A description of the ERA for MIR162, a
maize event expressing the Vip3A protein, has been published
(Raybould and Vlachos, 2011). The bioassays were conducted
using species representing functional groups of foliar arthropods,
soil-dwelling invertebrates, pollinators, wild birds and mammals,
aquatic invertebrates and farmed or wild fish (Raybould and
Vlachos, 2011). In addition tomortality, sublethal endpoints such
as fecundity, weight increase, adult emergence, body weight, and
length were recorded for some of the species tested. Depending
on the species, worst-case, or conservative maximum expected
environmental concentrations were used.
DISCUSSION
Sublethal Endpoints Are Addressed in the
Context of Existing Frameworks for NTO
Assessment
The rationale for conducting NTO studies in support of
regulatory risk assessments is not dependent on whether the
studies are designed to measure mortality or sublethal endpoints.
Before a study is conducted, the problem formulation process
should identify a set of informative tests based on the pathways
of environmental exposure, and an identification of relevant taxa
and functional groups for which risk should be assessed. Once
the appropriate tests are identified, consideration can be given
to what sort of measurement endpoints will best inform the
assessment. Whenmaking these decisions, it is important to keep
in mind the practical limitation associated with NTO testing and
risk assessment.
Absence of a Single Definitive Test or
Sublethal Endpoint
As with other types of testing, there is no single definitive
test that can address every possibility of sublethal effects. As is
typical of the regulatory risk assessment process, consideration
of whether a test is necessary should be done on a case-by-
case basis, focusing on the value of the information for reaching
conclusions about overall risk. Although flexibility in testing
allows sublethal tests to be tailored to specific needs of a
chosen test system, non-uniformity in testing procedures can
make it difficult to compare results obtained by independent
researchers conducting experiments and then reporting sublethal
impacts in the literature. These comparisons may provide
helpful context for regulatory considerations. The endpoints that
have been previously utilized to measure sublethal effects for
all types of insect-active GE plants (i.e., weight, growth and
developmental time, fecundity) appear to be useful and sufficient
for sublethal testing of non-Bt Cry insect actives, both protein-
based and dsRNA-based.
Effect of the Active on the Target Can
Indicate the Utility of Sublethal Endpoints
in NTO Testing
Knowledge regarding the mode of action and time to effect,
as it relates to the effect of the insect active on the target
insect, is instructive for ascertaining whether sublethal endpoint
testing is likely warranted in NTOs. For example, if an insect
active targets a cellular process that broadly affects growth (e.g.,
protein synthesis) it may be reasonably expected that collection of
data measuring sublethal endpoints such as weight, development
time, and reproduction may be warranted. If those endpoints
are affected in the target organism, they may also be affected in
NTOs. Additionally, the time that it takes for sublethal effects to
manifest in the target organism during lethality testing may also
be an indication that sublethal endpoint testing is warranted for
NTO assessment. If mortality in the target organism is delayed,
but indications of mortality are evident earlier due to the onset
of sublethal effects such as delayed growth or development, then
it may make sense to look for these effects in NTO assessment
as well.
Sublethal Endpoints Need to Relate to
Ecologically Relevant Assessment
Endpoints
Sublethal endpoints that relate to measurable ecologically
relevant endpoints will be much easier to interpret than more
complicated endpoints. Typically, measurement endpoints for
sublethal effects that include development time, growth/weight
and reproduction are used for data collection, and these
endpoints are readily quantifiable and relatable to assessment
endpoints such as population size. While a variety of additional
sublethal endpoints reflecting more ambiguous measurements
have been reported in the published literature (i.e., feeding
behavior and learning performance; Ramirez-Romero et al.,
2008), the interpretation of these endpoints with respect to
ecological outcomes is challenging.
Practical Considerations for Developing
New Test Systems
Any NTO testing is dependent on the existence or the
development of a well-characterized and validated test system.
Some existing test systems may lend themselves to the
collection of sublethal endpoint data, but others may not. Thus,
development of new test systems may be required when and if
the problem formulation indicates that a particular insect active
is likely to cause sublethal effects in relevant NTOs. In either
case, before the tests are conducted it is important to assure that
the results of the sublethal measurements will be meaningful for
risk assessment.
Addressing Knowledge Deficits
For RNAi-based insect actives, bioinformatics will become
increasingly important in predicting potential adverse effects
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associated with exposure to dsRNA. However, there are currently
significant gaps in bioinformatics data for both pest organisms
and for ecologically important taxonomic groups, as well as a
lack of information on which taxonomic groups are (in)sensitive
to environmental RNAi. Narrowing those information gaps will
provide a better understanding of the extent to which different
NTOs need to be assessed for a case-specific assessment for a
particular environmental RNAi.
More sublethal endpoint data are collected than is widely
acknowledged. In part, this is, due to the primary status of
mortality in testing guidelines and in summary reports or
journal publications where sublethal endpoint measurements
often are relegated to supplementary material. Finding new
means of sharing this information (and improving access to it)
is needed in the future to increase the potential usefulness of
this information for risk assessments. Similarly, data collected
during early characterization of pesticidal proteins may be
considered proprietary in nature, presenting a barrier to broad
distribution. Whenever possible, however, mechanisms should
be encouraged to improve access to this type of information.
There are several recent examples where early characterization
of pesticidal molecules have been published (Bachman et al.,
2013, 2017; Boeckman et al., 2019). However, the research
community is encouraged to find new means of storing and
disseminating information that often is omitted from peer-
reviewed publications but has value as a collective resource in
further development of NTO risk assessment methodology.
CONCLUSIONS
NTO testing is conducted in support of regulatory decision
making, and therefore must be designed for this purpose, rather
than simply to conduct scientifically interesting experiments
(Raybould, 2010). The testing associated with any particular
insect-active GE crop should be informed by a problem
formulation process. Problem formulation takes into account
what is known about the insect-active protein, the crop, and
the expected interactions between NTOs and the associated
insect-active crop, as well as the availability of well-developed
test systems that facilitate the interpretation of test results in a
regulatory context. The problem formulation process remains
fundamentally the same whether the measurement endpoint
is mortality or sublethal endpoints. When selecting sublethal
endpoints for consideration, a risk hypothesis should link
the sublethal endpoint to an assessment endpoint and the
associated protection goal. Because most NTOs are protected at
the population level and NTO communities at the functional
level, typically, sublethal endpoints that are related to growth,
development, and reproduction and which can be easily
extrapolated to population level effects are most informative.
While additional sublethal endpoints might be measurable, they
should only be considered for regulatory testing if there is a
clear relationship to a protection goal and the results are likely
to reduce uncertainties associated with the NTO assessment. A
review of recent and past measurement of sublethal endpoints
collected to inform regulatory studies of plant incorporated
insecticidal Bt Cry proteins is summarized in Table 1. These data
suggest sublethal endpoints for current insect resistant GE crops
are observed and measured more routinely than is often claimed
in the literature.
A long history of standardization exists that can inform
the future of NTO testing. While standard methods are not
absolutely required for testing possible sublethal impacts, such
studies can be informative for risk assessment. However, for these
studies to be informative, there should be a clear understanding
of what data are being collected and what is the rationale for
collecting them. When published in peer reviewed publications,
these sublethal endpoints are often published as supplemental
data. If sublethal testing is done, and data are reported, these data
should be presented more prominently in research reports. This
practice would promote a broader understanding and further
discussion of the utility of sublethal endpoints and enhance their
usefulness to the risk assessment process.
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